All Stories

  1. New Generation of Clinical Epigenetics Analysis and Diagnosis for Precision Medicine
  2. Cholesterol‐conjugated miR‐29b induces fetal haemoglobin expression via γ‐globin promoter demethylation in the Townes mouse model for sickle cell anaemia
  3. Precision Medicine Related to Landscape and Architecture of Tumor Specimen
  4. STAT3 down-regulation for IL-2 inducing TIL-A clinical clue for spatial quantitative pathway analysis
  5. Editorial: Epigenetics in cancer: mechanisms and drug development-volume II
  6. Spatial-timely Quantitative Network Analysis for TGF-β pathway of Tumor Infiltrating Lymphocytes
  7. Epigenetics in Cancer: Mechanisms and Drug Development - Volume II
  8. Personalized Immunotherapy of Patients: Defining by Single-cell RNA-seq with Artificial Intelligence
  9. "Machine-learning Modeling for Personalized Immunotherapy- An Evaluation Module"
  10. Why do tumor-infiltrating lymphocytes have variable efficacy in the treatment of solid tumors?
  11. Editorial: Epigenetics in Cancer: Mechanisms and Drug Development
  12. Salubrinal induces fetal hemoglobin expression via the stress-signaling pathway in human sickle erythroid progenitors and sickle cell disease mice
  13. Novel histone deacetylase inhibitor CT-101 induces γ-globin gene expression in sickle erythroid progenitors with targeted epigenetic effects
  14. Salubrinal induces fetal hemoglobin expression via the stress-signaling pathway in human sickle erythroid progenitors and sickle cell disease mice
  15. Benserazide racemate and enantiomers induce fetal globin gene expression in vivo: Studies to guide clinical development for beta thalassemia and sickle cell disease
  16. Conjugate prodrug AN-233 induces fetal hemoglobin expression in sickle erythroid progenitors and β-YAC transgenic mice
  17. In silico Modeling Personalized Therapy of Pulmonary Artery Hypertension
  18. MIR29B mediates epigenetic mechanisms of HBG gene activation
  19. MIR-144-mediated NRF2 gene silencing inhibits fetal hemoglobin expression in sickle cell disease
  20. Mechanisms of NRF2 activation to mediate fetal hemoglobin induction and protection against oxidative stress in sickle cell disease
  21. Fetal hemoglobin induction in sickle erythroid progenitors using a synthetic zinc finger DNA-binding domain
  22. Dimethyl fumarate increases fetal hemoglobin, provides heme detoxification, and corrects anemia in sickle cell disease
  23. Pathway-Based Approaches for Analysis of Genome-wide Association Studies--A case report for metastatic small cell lung cancer
  24. NRF2 mediates γ-globin gene regulation and fetal hemoglobin induction in human erythroid progenitors
  25. Personalized Chemotherapy of Tumor Disease Based on System Modeling
  26. Original Research: Stable expression of miR-34a mediates fetal hemoglobin induction in K562 cells
  27. Novel Inducers of Fetal Globin Identified through High Throughput Screening (HTS) Are Active In Vivo in Anemic Baboons and Transgenic Mice
  28. Cell signaling pathways involved in drug-mediated fetal hemoglobin induction: Strategies to treat sickle cell disease
  29. Personalized Targeted Prevention and Therapy Relied on Detection of Global and Local Single Nucleotide Polymorphisms
  30. A Cell-Based High-Throughput Screen for Novel Chemical Inducers of Fetal Hemoglobin for Treatment of Hemoglobinopathies
  31. Characterization of Transcription Factor Networks Involved in Umbilical Cord Blood CD34+ Stem Cells-Derived Erythropoiesis
  32. Monomethylfumarate Induces γ-Globin Expression and Fetal Hemoglobin Production in Cultured Human Retinal Pigment Epithelial (RPE) and Erythroid Cells, and in Intact Retina
  33. Feasibility of Whole RNA Sequencing from Single-Cell mRNA Amplification
  34. Characterization of the transcriptome profiles related to globin gene switching during in vitro erythroid maturation
  35. Gene Expression and Pathway Analysis of Quiescent CD8+ T Cells from Liver Cancer, Liver Sinusoid and Peripheral Blood - Study on Toxicogenomics and Prevention Targeting
  36. Genomic expression analysis by single‐cell mRNA differential display of quiescent CD8 T cells from tumour‐infiltrating lymphocytes obtained from in vivo liver tumours
  37. SRY-directed DNA Bending and Human Sex Reversal: Reassessment of a Clinical Mutation Uncovers a Global Coupling between the HMG Box and its Tail
  38. Regulation of Sexual Dimorphism: Mutational and Chemogenetic Analysis of the Doublesex DM Domain
  39. A strategy to identify genomic expression at single-cell level or a small number of cells
  40. Enhancing the Activity of Insulin at the Receptor Interface:  Crystal Structure and Photo-Cross-Linking of A8 Analogues
  41. How Insulin Binds: the B-Chain α-Helix Contacts the L1 β-Helix of the Insulin Receptor
  42. Expression, crystallization and preliminary X-ray characterization of theDrosophilatranscription factor Doublesex
  43. The Effects of the Farnesyl Transferase Inhibitor FTI L-778,123 on Normal, Myelodysplastic, and Myeloid Leukemia Bone Marrow Progenitor Proliferation In Vitro
  44. Sex-specific Gene Regulation
  45. Abnormalities of molecular regulators of proliferation and apoptosis in carcinoma of the oral cavity and oropharynx
  46. Experimental and bioinformatics comparison of gene expression between T cells from TIL of liver cancer and T cells from UniGene
  47. Human Sex Reversal Due to Impaired Nuclear Localization of SRY
  48. P15INK4B gene methylation and expression in normal, myelodysplastic, and acute myelogenous leukemia cells and in the marrow cells of cured lymphoma patients
  49. Poor prognosis acute myelogenous leukemia: 3—biological and molecular biological changes during remission induction therapy
  50. Alterations in IRF1/IRF2 expression in acute myelogenous leukemia
  51. SRY and Architectural Gene Regulation: The Kinetic Stability of a Bent Protein-DNA Complex Can Regulate Its Transcriptional Potency
  52. Quantitation of Interferon Regulatory Factor Transcripts in Patients with Acute Myeloid Leukemia
  53. In VivoEffects of IL-4, IL-10, and Amifostine on Cytokine Production in Patients with Acute Myelogenous Leukemia
  54. Poor prognosis acute myelogenous leukemia 2 — biological and molecular biological characteristics and treatment outcome
  55. Identification of mRNAs expressed in tumor-infiltrating lymphocytes by a strategy for rapid and high throughput screening
  56. Immunologic character of tumor infiltrating lymphocytes in ovarian carcinoma
  57. SCF, IL-1β, IL-1ra AND GM-CSF IN THE BONE MARROW AND SERUM OF NORMAL INDIVIDUALS AND OF AML AND CML PATIENTS
  58. Signal antonymy unique to myelodysplastic marrows correlates with altered expression of E2F1
  59. Telomerase Activity In Preleukemia And Acute Myelogenous Leukemia
  60. Marrow Cytokine Transcripts and the Secondary Hematologic Disorders
  61. Cytokine gene activity in AML cells in vivo in patients
  62. Abnormal regulation of the myc gene in myeloid leukemia